Tufts Center for the Study of Drug Development
75 Kneeland Street
Suite 1100
Boston, MA 02111
 | kenneth.kaitin@tufts.edu |
Dr. Kaitin is a Professor at Tufts University School of Medicine and Director of the Tufts Center for the Study of Drug Development. Dr. Kaitin also holds appointments as Advisory Professor at Shanghai Medical College of Fudan University in Shanghai, China; Visiting Executive at the Tuck School of Business at Dartmouth College; and faculty of the European Center for Pharmaceutical Medicine at the University of Basel. An internationally recognized expert on drug development science and policy, Dr. Kaitin writes and speaks regularly on factors that contribute to the slow pace and high cost of pharmaceutical R&D and efforts to improve the development process. He has provided public testimony before the U.S. Congress on pharmaceutical development, regulation, and policy issues, and he currently serves as an expert consultant to the U.S. Department of Defense on bioterror countermeasures initiatives. Dr. Kaitin is frequently quoted in the business and trade press on global R&D trends and new models of innovation. A former President of the Drug Information Association, Dr. Kaitin is currently Editor-in-Chief of Expert Review of Clinical Pharmacology. He is on the editorial boards of a number of peer-review journals, and he serves on the boards of directors of several public, private, and not-for-profit life sciences companies and organizations. In 2011, Dr. Kaitin received the Dr. Louis M. Sherwood Award, granted by the Academy of Pharmaceutical Physicians and Investigators. Dr. Kaitin received a B.S. from Cornell University and an M.S. and Ph.D. in pharmacology from the University of Rochester.
